Advertisement Drug prices remain stable in Germany - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Drug prices remain stable in Germany

The research-based pharmaceutical companies association, VFA, has said that the medicine prices in Germany this April will be 1.4% lower compared to April 2007.

According to the data from Insight Health, for 92% of the 84,000 pharmaceutical products available, prices will be the same as last month, while 4.4% of them will become cheaper and 3.8% more expensive.

Despite price stability, the health insurance companies have incurred a rise in their pharmaceutical spending because of the ageing population, the improved treatment of national diseases such as hypertension, and the availability of new vaccines.